A recent study analyzed the effects of radiofrequency ablation versus stereotactic body radiotherapy in patients with non-surgically managed localized hepatocellular carcinoma.

News

A recent study analyzed the effects of radiofrequency ablation versus stereotactic body radiotherapy in patients with non-surgically managed localized hepatocellular carcinoma.
Researchers found that patients who achieve complete response on a common therapy for hepatocellular carcinoma are at a higher risk for developing dermatologic adverse events.

By Marilynn Larkin

NEW YORK (Reuters Health) – Individualizing radiotherapy according to levels of a patient-specific biomarker of liver function safely achieves local control in cancer patients at high risk for liver damage, researchers say.

Read More

By Shereen Lehman

(Reuters Health) - Death rates from liver cancer in the U.S. have doubled since the 1980s and continue to rise, largely due to risk factors like hepatitis that should be the focus of better treatment and prevention efforts, researchers say.

Read More

Research in Review

A study of image-guided percutaneous liver biopsy (PLB) in patients with hepatocellular carcinoma has found that the procedure is increasingly being used in recent years despite safety concerns as well as rising costs associated with the procedure. 

Read More

Subscribe to Liver Cancer